Evidence map›Paper›PMID 42059812›Full record

ArticleAntimicrobial agents and chemotherapy2026

Sulbactam-durlobactam and cefiderocol combination treatment of

Bhavita Gaglani, Tessa M Andermann, Claire Wate, Jorge Oldan, Chirag S Desai, Steven H Marshall, Robert A Bonomo, Ray Coakley, David van Duin, Anne Lachiewicz

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Case Commentary: When susceptibility is not enough in recurrentAntimicrobial agents and chemotherapy · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Bhavita GaglaniDepartment of Medicine and Anesthesiology, Wake Forest School of Medicine, Winston Salem, North Carolina, USA.ORCID 0000-0002-5620-9888
Tessa M AndermannDepartment of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Claire WateInstitute of Global Health & Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, USA.
Jorge OldanDepartment of Radiology, Molecular Imaging and Therapeutics, University of North Carolina, Chapel Hill, North Carolina, USA.
Chirag S DesaiDivision of Abdominal Transplant, Department of Surgery, University of North Carolina, Chapel Hill, North Carolina, USA.
Steven H MarshallResearch Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA.
Robert A BonomoResearch Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA.ORCID 0000-0002-3299-894X
Ray CoakleyDepartment of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
David van DuinDepartment of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.ORCID 0000-0003-4784-3227
Anne LachiewiczDepartment of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

Funding

NIH HHS AI163365
6 · The paper itself

Abstract

A 50-year-old woman with cystic fibrosis (CF) and lung transplantation developed persistent deep abscesses due to multidrug-resistant (MDR)

Indexed as

Anti-Bacterial AgentsBurkholderia cenocepaciaBurkholderia InfectionsCephalosporinsSulbactamCefiderocolCystic FibrosisDrug Resistance, Multiple, BacterialDrug Therapy, CombinationFemaleHumansLung TransplantationMiddle AgedAnti-Bacterial AgentsCefiderocolCephalosporinsSulbactamBurkholderia cepacia complexcefiderocolcystic fibrosislung transplantationmultidrug resistancesulbactam–durlobactam

Identifiers

PMID42059812
PMCPMC13321792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.